The mean values of CD3+CD4+, CD16+CD56+, CD4/CD8 ratio, CD3+CD4+%, and CD16+CD56+% in COVID-19 patients were significantly higher than those in patients with CAP. Here, NCAM1 is linked to COVID-19.